These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Nalidixic acid (Neggram) in the treatment of chronic non-specific urinary tract infections]. Porpáczy P; Haschek H; Zischka-Konorsa W; Hermanek P; Bibus B Wien Klin Wochenschr; 1968 Feb; 80(5):87-93. PubMed ID: 5667719 [No Abstract] [Full Text] [Related]
6. [A clinical evaluation of nalidixic acid in the urinary tract infections (urinary tract infections in paraplegics. I)]. Naito M; Kawada Y; Kondo M; Isomi A Hinyokika Kiyo; 1967 Jul; 13(7):561-6. PubMed ID: 5625177 [No Abstract] [Full Text] [Related]
7. [Use of nevigramon in acute and chronic pyelonephritis before and after kidney transplantation]. Iarmolinskiĭ IS; Vasina TA; Ploshkina NS; Goriaĭnov VA Antibiotiki; 1971 Feb; 16(2):177-9. PubMed ID: 4997523 [No Abstract] [Full Text] [Related]
8. A critical evaluation of nalidixic acid in urinary-tract infections. Ronald AR; Turck M; Petersdorf RG N Engl J Med; 1966 Nov; 275(20):1081-9. PubMed ID: 5923022 [No Abstract] [Full Text] [Related]
9. [Nalidixic acid (Wintomylon) and bacterial resistance to antibiotics in urinary tract infections]. Makino M Hinyokika Kiyo; 1968 Jun; 14(6):351-6. PubMed ID: 4882490 [No Abstract] [Full Text] [Related]
10. [A clinical evaluation of Wintomylon in the treatment of urinary infections]. Inada T; Ebisuta K; Kitayama T; Miyakawa M Hinyokika Kiyo; 1966 Oct; 12(10):1150-5. PubMed ID: 6008094 [No Abstract] [Full Text] [Related]
11. Letter: nalidixic acid in "full" dosage. Bailey RR N Z Med J; 1974 Sep; 80(523):226. PubMed ID: 4530203 [No Abstract] [Full Text] [Related]
13. [Study of nalidixic acid activity on 3186 strains of Gram negative bacilli. Application to the treatment of urinary infections]. Chamfeuil R; Curcier H Presse Med (1893); 1969 Nov; 77(48):1763-4. PubMed ID: 4903534 [No Abstract] [Full Text] [Related]
14. [Drug-resistant organisms in urinary tract infections and clinical use of Wintomylon (nalidixic acid)]. Kuze M; Kashiwagi T; Okita J; Komiya T; Nihira H Hinyokika Kiyo; 1966 Mar; 12(3):291-6. PubMed ID: 6006673 [No Abstract] [Full Text] [Related]
15. [Nalidixic acid in urinary tract infections--a reply]. Abel JA Lakartidningen; 1969 Jan; 66(4):298-9. PubMed ID: 5767421 [No Abstract] [Full Text] [Related]
16. Sulphadimidine and nalidixic acid therapy in urinary-tract infections in general practice. Brown PC; Donaghy MC; Dootson PH; Titcombe DH; MacLaren DM Practitioner; 1971 Dec; 207(242):819-26. PubMed ID: 4947233 [No Abstract] [Full Text] [Related]
17. Nalidixic acid in acute and chronic urinary tract infections. Zinsser HH Med Clin North Am; 1970 Sep; 54(5):1347-50. PubMed ID: 4248514 [No Abstract] [Full Text] [Related]
18. The clinical use of nalidixic acid. A review and some observations. Stamey TA; Nemoy NJ; Higgins M Invest Urol; 1969 May; 6(6):582-92. PubMed ID: 4976942 [No Abstract] [Full Text] [Related]
19. [Comparison of antibacterial activity of oxolinic acid (Gramurin) and nalidixic acid (Nevigramon) in vitro and in patients with urinary tract infections]. Manitius A; Hebanowski M; Galiński J; Nowicki B Pol Tyg Lek; 1978 Aug; 33(34):1347-50. PubMed ID: 704439 [No Abstract] [Full Text] [Related]